
Will a Phase III hantavirus vaccine trial report positive results in 2026?
Started
Ends
00
MTH
00
DAY
00
HRS
00
MIN
00
SEC

Will a Phase III hantavirus vaccine trial report positive results in 2026?
Ends
00
MTH
00
DAY
00
HRS
00
MIN
00
SEC
About this Market
Measures whether researchers announce a successful hantavirus vaccine trial globally.
1 traders/$1 total volume
| User | Side | Amount | Date |
|---|---|---|---|
| YES | $1 USDC |
Discussion
0 commentsNo discussion yet.